TABLE 4.
IL−23 | IL−17A | sIL−23R | sIL−17RA | PD | CAL | % BoP | % RBL | ESR | CRP | FR | TJC | SJC | DAS28‐ESR | HAQ‐DI | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IL−23 | r | 1.000 | 0.256* | −0.166 | 0.282* | −0.272* | −0.164 | −0.032 | −0.177 | 0.155 | 0.208 | 0.179 | −0.142 | 0.148 | −0.089 | −0.134 |
p | 0.013 | 0.081 | 0.002 | 0.004 | 0.089 | 0.762 | 0.199 | 0.149 | 0.262 | 0.361 | 0.331 | 0.310 | 0.538 | 0.370 | ||
IL−17A | r | 1.000 | −0.126 | 0.392* | −0.175 | −0.226* | −0.070 | −0.012 | 0.004 | 0.033 | −0.016 | −0.046 | −0.005 | −0.125 | −0.276 | |
p | 0.195 | ≤0.001 | 0.077 | 0.023 | 0.497 | 0.934 | 0.973 | 0.866 | 0.936 | 0.748 | 0.974 | 0.379 | 0.055 | |||
sIL−23R | r | 1.000 | 0.275* | 0.219* | 0.072 | −0.289* | −0.019 | −0.292* | −0.010 | 0.271 | −0.166 | −0.005 | −0.132 | −0.047 | ||
p | ≤0.001 | 0.014 | 0.433 | 0.003 | 0.888 | 0.003 | 0.954 | 0.148 | 0.222 | 0.970 | 0.327 | 0.739 | ||||
sIL−17RA | r | 1.000 | 0.149 | 0.029 | −0.151 | −0.030 | −0.097 | 0.126 | −0.096 | −0.042 | −0.009 | −0.052 | 0.015 | |||
p | 0.094 | 0.752 | 0.120 | 0.825 | 0.327 | 0.476 | 0.608 | 0.758 | 0.950 | 0.702 | 0.918 | |||||
PD | r | 1.000 | .819** | 0.321* | 0.223 | −0.205* | −0.072 | −0.088 | 0.210 | 0.174 | 0.147 | −0.050 | ||||
p | ≤0.001 | 0.001 | 0.096 | 0.042 | 0.687 | 0.638 | 0.121 | 0.200 | 0.274 | 0.723 | ||||||
CAL | r | 1.000 | 0.327* | 0.136 | −0.112 | −0.252 | −0.055 | 0.109 | 0.272* | 0.080 | −0.082 | |||||
p | ≤0.001 | 0.312 | 0.279 | 0.150 | 0.767 | 0.423 | 0.043 | 0.556 | 0.561 | |||||||
% BoP | r | 1.000 | 0.135 | 0.132 | −0.312 | −0.107 | −0.033 | −0.125 | −0.059 | −0.169 | ||||||
p | 0.315 | 0.189 | 0.072 | 0.567 | 0.812 | 0.358 | 0.662 | 0.230 | ||||||||
% RBL | r | 1.000 | −0.095 | −0.021 | −0.038 | 0.130 | 0.180 | 0.088 | −0.003 | |||||||
p | 0.508 | 0.931 | 0.881 | 0.455 | 0.300 | 0.610 | 0.987 | |||||||||
ESR | r | 1.000 | 0.267 | 0.010 | 0.291* | 0.115 | 0.488** | 0.186 | ||||||||
p | 0.127 | 0.957 | 0.028 | 0.393 | ≤0.001 | 0.183 | ||||||||||
CRP | r | 1.000 | 0.071 | 0.256 | 0.470* | 0.441* | 0.429* | |||||||||
p | 0.710 | 0.144 | 0.005 | 0.009 | 0.014 | |||||||||||
FR | r | 1.000 | −0.034 | 0.069 | −0.085 | 0.076 | ||||||||||
p | 0.855 | 0.712 | 0.649 | 0.696 | ||||||||||||
TJC | r | 1.000 | 0.544** | 0.852** | 0.609** | |||||||||||
p | ≤0.001 | ≤0.001 | ≤0.001 | |||||||||||||
SJC | r | 1.000 | 0.701** | 0.415* | ||||||||||||
p | ≤0.001 | 0.002 | ||||||||||||||
DAS28‐ESR | r | 1.000 | 0.603** | |||||||||||||
p | ≤0.001 | |||||||||||||||
HAQ‐DI | r | 1.000 | ||||||||||||||
p |
Spearman correlation test.
Abbreviations: % BoP, bleeding of probing; % RBL, radiographic bone loss; CAL, clinical of attachment level; CRP, C‐reactive protein; DAS28‐ESR, Disease Activity Score; ESR, erythrocyte sedimentation rate; HAQ‐DI, Health Assessment Questionnaire Disability Index; PD, probe depth; RF, rheumatoid factor; SJC, swollen joint count; TJC, tender joint count.
Values in bold are significant.
*p < 0.050 ** p < 0.010.